Study identifier: NCT05811247 Synced from ClinicalTrials.gov · August 05, 2026
● Completed

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Condition: OSA  ·  Sponsor: Apnimed

PhasePhase 3
Planned participants660
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (64)

Sleep Disorders Center of AlabamaBirmingham, Alabama, United States
Chandler Clinical TrialsChandler, Arizona, United States
Preferred Research Partners, Inc.Little Rock, Arkansas, United States
Orange County Research InstituteAnaheim, California, United States
Marvel Clinical Research, LLCHuntington Beach, California, United States
CenExel CNSLos Alamitos, California, United States
Santa Monica Clinical TrialsLos Angeles, California, United States
Empire Clinical ResearchPomona, California, United States
Pacific Research NetworkSan Diego, California, United States
SDS Clinical Trials Inc.Santa Ana, California, United States
Alpine Clinical Research CenterBoulder, Colorado, United States
Mountain View Clinical Research, Inc.Denver, Colorado, United States

+ 52 more locations — full list on the registry record.

Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →